Development of GLUT4-selective antagonists for multiple myeloma therapy-Reference-Cited by-同舟云学术

Development of GLUT4-selective antagonists for multiple myeloma therapy

Published:2017-10 Issue: Volume:139 Page:573-586
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wei Changyong,Bajpai Richa,Sharma Horrick,Heitmeier Monique,Jain Atul D.,Matulis Shannon M.,Nooka Ajay K.,Mishra Rama K.,Hruz Paul W.,Schiltz Gary E.^ORCID,Shanmugam Mala

Funder

Center for Molecular Innovation and Drug Discovery (CMIDD)

Chicago Biomedical Consortium

The Chicago Community Trust, and Cancer Center

National Cancer Institute

American Cancer Society Research scholar

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference66 articles.

1. On the origin of cancer cells;Warburg;Science,1956

2. Why do cancers have high aerobic glycolysis?;Gatenby;Nat. Rev. Cancer,2004

3. The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi;Castellani;Clin. Nucl. Med.,2010

4. Whole-body (18)F-FDG PET identifies high-risk myeloma;Durie;J. Nucl. Med.,2002

5. Value of FDG PET in the assessment of patients with multiple myeloma;Bredella;AJR Am. J. Roentgenol.,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycolysis, the sweet appetite of the tumor microenvironment;Cancer Letters;2024-09

2. Targeting metabolism to enhance immunotherapy within tumor microenvironment;Acta Pharmacologica Sinica;2024-05-29

3. Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance;European Journal of Medicinal Chemistry;2024-05

4. Small-molecule inhibitors of glucose transporters;Vitamins and Hormones;2024

5. Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma;Cancer Research;2023-09-11